Render Biotech Co.
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $15M
Investors
- 3
About Render Biotech Co.
, Ltd., Ltd. focuses on high-tech healthcare solutions. The company has engaged in 2 notable deals, with the most recent deal occurring on July 6, 2021., Ltd. specializes in high-tech healthcare solutions, primarily focusing on hemostasis, point-of-care testing (POCT), and microbiology products. Their offerings are designed to enhance diagnostic accuracy and efficiency in clinical environments, addressing critical needs in patient care and disease management. These products are utilized in various healthcare settings, including hospitals, clinics, and laboratories, allowing healthcare professionals to obtain rapid and reliable test results. Render Biotech's solutions cater to a diverse client base that includes healthcare providers and laboratories across international markets, with notable distribution in Asia, Europe, and North America., Ltd. generates revenue through a structured model involving direct sales to healthcare facilities and partnerships with distributors. The company's business transactions typically encompass bulk orders and contractual agreements with healthcare providers, allowing for streamlined procurement processes. Render Biotech’s flagship products, such as their hemostasis and microbiology testing kits, are positioned at competitive pricing, appealing to both B2B clients and direct consumers. This transactional framework supports sustained revenue growth by fostering long-term relationships with healthcare institutions and ensuring a steady demand for their innovative products., Ltd. The company is focused on designing and launching new products in the hemostasis and POCT sectors, with anticipated releases throughout 2022. Additionally, Render Biotech aims to expand its reach into new markets, specifically targeting growth in Europe and North America by the end of 2023.
Who invested in Render Biotech Co.
3 investors across 2 rounds
See all investors in Render Biotech Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Render Biotech Co.
Who invested in Render Biotech Co.?
Render Biotech Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Render Biotech Co. raised?
Render Biotech Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Render Biotech Co. last raise money?
Render Biotech Co.'s most recent round on record is a Series A, in Jul 2021.
What does Render Biotech Co. do?
Render Biotech Co. is a medical devices & equipment company.
Where is Render Biotech Co. headquartered?
Render Biotech Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Render Biotech Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Render Biotech Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Render Biotech Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.